hims hers weight loss

Hims, Hers Health Stock

Hosted on MSN · 1h

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.

The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.

The Motley Fool on MSN · 18m

Why Hims & Hers Health Stock Is Plummeting Today

Shares of Hims & Hers Health ( HIMS -24.30%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost as much as 26.1% earlier in the day. The move comes as the S&P 500 lost 1% and the Nasdaq Composite lost 1.3%.

SchaeffersResearch.com · 3h

Hims and Hers Stock Drops Weight as Earnings Loom

Healthcare stock Hims and Hers (HIMS) is sharply lower today but has contrarian potential next week ahead of earnings

Money Morning · 3h

Why Is HIMS Stock Down So Much? Should You Buy?

HIMS stock plunged by 18% after the FDA news that resolved a shortage of weight-loss drugs like Ozempic and Wegovy, which previously allowed Hims & Hers to sell compounded alternatives. Compounded versions were permitted during the shortage but are now restricted unless they meet specific exceptions.

The Motley Fool on MSN · 1d

Why Hims & Hers Stock Dropped Today

Hims & Hers Health (NYSE: HIMS) tumbled 5.6% through 12:20 p.m. ET Thursday after Bank of America analysts gave mixed messages on the stock this morning. Raising its price target on the shares to $21,

Hims, weight loss and Novo Nordisk

Seeking Alpha · 6h

Hims & Hers plunges as the FDA says Novo’s weight loss drugs are not in shortage

Hims & Hers Health (HIMS) stock falls as the FDA declares that Novo Nordisk's (NVO) weight loss therapies are no longer in shortage in the U.S. Read more here.

ABC · 9d

Super Bowl ad for Hims & Hers' weight loss drug sparks backlash

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, which both contain the active ingredient semaglutide and are approved by the U.S. Food and Drug Administration to treat Type 2 diabetes and obesity, respectively.

MarketWatch · 3h

Hims & Hers Health Shares Tumble After Novo Nordisk Says Wegovy, Ozempic Shortage is Over

Shares tumbled 21% to $52.22. Over the last year, the stock has surged more than 450%.

4hon MSN

Hims & Hers to offer at-home blood draws, lean into 'peptide innovations' with new acquisitions

The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Analysts explain why Hims & Hers stock is crashing today

On Friday, shares of Hims&Hers Health Inc (NYSE:HIMS) dropped over 20% following an FDA announcement that the supply shortage of Novo Nordisk (NYSE:NVO)'s weight loss and diabetes drugs was ending.

3hon MSN

HIMS stock crashes 25% on Friday after this key FDA update

The massive crash came after the US Food and Drug Administration (FDA) website showed the end of the shortage of Novo Nordisk ...

2don MSN

Hims & Hers Buys Lab to Expand Into At-Home Blood Testing

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results